Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Commercial Assays/Tests
1.2.3 Laboratory Developed Tests
1.2.4 Direct to Consumer Test
1.2.5 Pre-Commercial Tests
1.3 Market by Application
1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-Based Monitoring and Diagnostic Test Market Perspective (2018-2033)
2.2 NGS-Based Monitoring and Diagnostic Test Growth Trends by Region
2.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 NGS-Based Monitoring and Diagnostic Test Historic Market Size by Region (2018-2023)
2.2.3 NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2024-2033)
2.3 NGS-Based Monitoring and Diagnostic Test Market Dynamics
2.3.1 NGS-Based Monitoring and Diagnostic Test Industry Trends
2.3.2 NGS-Based Monitoring and Diagnostic Test Market Drivers
2.3.3 NGS-Based Monitoring and Diagnostic Test Market Challenges
2.3.4 NGS-Based Monitoring and Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-Based Monitoring and Diagnostic Test Players by Revenue
3.1.1 Global Top NGS-Based Monitoring and Diagnostic Test Players by Revenue (2018-2023)
3.1.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Players (2018-2023)
3.2 Global NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-Based Monitoring and Diagnostic Test Revenue
3.4 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio
3.4.1 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
3.5 NGS-Based Monitoring and Diagnostic Test Key Players Head office and Area Served
3.6 Key Players NGS-Based Monitoring and Diagnostic Test Product Solution and Service
3.7 Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Type
4.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Type (2018-2023)
4.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2024-2033)
5 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Application
5.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Application (2018-2023)
5.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
6.2 North America NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
6.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
7.2 Europe NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
7.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
8.2 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023)
8.4 Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
9.2 Latin America NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
9.4 Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
10.2 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
10.4 Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Detail
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Ancestry.com LLC
11.2.1 Ancestry.com LLC Company Detail
11.2.2 Ancestry.com LLC Business Overview
11.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction
11.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.2.5 Ancestry.com LLC Recent Development
11.3 ArcherDX, Inc.
11.3.1 ArcherDX, Inc. Company Detail
11.3.2 ArcherDX, Inc. Business Overview
11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.3.5 ArcherDX, Inc. Recent Development
11.4 Beijing Genomics Institute (BGI)
11.4.1 Beijing Genomics Institute (BGI) Company Detail
11.4.2 Beijing Genomics Institute (BGI) Business Overview
11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction
11.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.4.5 Beijing Genomics Institute (BGI) Recent Development
11.5 Cancer Genetics, Inc.
11.5.1 Cancer Genetics, Inc. Company Detail
11.5.2 Cancer Genetics, Inc. Business Overview
11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.5.5 Cancer Genetics, Inc. Recent Development
11.6 CENTOGENE AG
11.6.1 CENTOGENE AG Company Detail
11.6.2 CENTOGENE AG Business Overview
11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction
11.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.6.5 CENTOGENE AG Recent Development
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Detail
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Ltd Recent Development
11.8 GenePath Dx
11.8.1 GenePath Dx Company Detail
11.8.2 GenePath Dx Business Overview
11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction
11.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.8.5 GenePath Dx Recent Development
11.9 Illumina, Inc.
11.9.1 Illumina, Inc. Company Detail
11.9.2 Illumina, Inc. Business Overview
11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.9.5 Illumina, Inc. Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Detail
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Myriad Genetics, Inc.
11.11.1 Myriad Genetics, Inc. Company Detail
11.11.2 Myriad Genetics, Inc. Business Overview
11.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.11.5 Myriad Genetics, Inc. Recent Development
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Detail
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction
11.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.12.5 QIAGEN N.V. Recent Development
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Detail
11.13.2 Quest Diagnostics Incorporated Business Overview
11.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction
11.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.13.5 Quest Diagnostics Incorporated Recent Development
11.14 Siemens Healthineers, Inc.
11.14.1 Siemens Healthineers, Inc. Company Detail
11.14.2 Siemens Healthineers, Inc. Business Overview
11.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.14.5 Siemens Healthineers, Inc. Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Detail
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
11.16 HTG Molecular Diagnostics, Inc.
11.16.1 HTG Molecular Diagnostics, Inc. Company Detail
11.16.2 HTG Molecular Diagnostics, Inc. Business Overview
11.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.16.5 HTG Molecular Diagnostics, Inc. Recent Development
11.17 Vela Diagnostics Pte. Ltd.
11.17.1 Vela Diagnostics Pte. Ltd. Company Detail
11.17.2 Vela Diagnostics Pte. Ltd. Business Overview
11.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction
11.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.17.5 Vela Diagnostics Pte. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Commercial Assays/Tests
Table 3. Key Players of Laboratory Developed Tests
Table 4. Key Players of Direct to Consumer Test
Table 5. Key Players of Pre-Commercial Tests
Table 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global NGS-Based Monitoring and Diagnostic Test Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2018-2023)
Table 10. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2024-2033)
Table 12. NGS-Based Monitoring and Diagnostic Test Market Trends
Table 13. NGS-Based Monitoring and Diagnostic Test Market Drivers
Table 14. NGS-Based Monitoring and Diagnostic Test Market Challenges
Table 15. NGS-Based Monitoring and Diagnostic Test Market Restraints
Table 16. Global NGS-Based Monitoring and Diagnostic Test Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players (2018-2023)
Table 18. Global Top NGS-Based Monitoring and Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)
Table 19. Ranking of Global Top NGS-Based Monitoring and Diagnostic Test Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players NGS-Based Monitoring and Diagnostic Test Product Solution and Service
Table 23. Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2018-2023)
Table 27. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2024-2033)
Table 29. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2018-2023)
Table 31. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application (2024-2033)
Table 33. North America NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 34. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 40. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 43. Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 46. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 48. Agilent Technologies, Inc. Company Detail
Table 49. Agilent Technologies, Inc. Business Overview
Table 50. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 51. Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 52. Agilent Technologies, Inc. Recent Development
Table 53. Ancestry.com LLC Company Detail
Table 54. Ancestry.com LLC Business Overview
Table 55. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product
Table 56. Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 57. Ancestry.com LLC Recent Development
Table 58. ArcherDX, Inc. Company Detail
Table 59. ArcherDX, Inc. Business Overview
Table 60. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 61. ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 62. ArcherDX, Inc. Recent Development
Table 63. Beijing Genomics Institute (BGI) Company Detail
Table 64. Beijing Genomics Institute (BGI) Business Overview
Table 65. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product
Table 66. Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 67. Beijing Genomics Institute (BGI) Recent Development
Table 68. Cancer Genetics, Inc. Company Detail
Table 69. Cancer Genetics, Inc. Business Overview
Table 70. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 71. Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 72. Cancer Genetics, Inc. Recent Development
Table 73. CENTOGENE AG Company Detail
Table 74. CENTOGENE AG Business Overview
Table 75. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product
Table 76. CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 77. CENTOGENE AG Recent Development
Table 78. F. Hoffmann-La Roche Ltd Company Detail
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product
Table 81. F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 82. F. Hoffmann-La Roche Ltd Recent Development
Table 83. GenePath Dx Company Detail
Table 84. GenePath Dx Business Overview
Table 85. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product
Table 86. GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 87. GenePath Dx Recent Development
Table 88. Illumina, Inc. Company Detail
Table 89. Illumina, Inc. Business Overview
Table 90. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 91. Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 92. Illumina, Inc. Recent Development
Table 93. Laboratory Corporation of America Holdings Company Detail
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product
Table 96. Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 97. Laboratory Corporation of America Holdings Recent Development
Table 98. Myriad Genetics, Inc. Company Detail
Table 99. Myriad Genetics, Inc. Business Overview
Table 100. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 101. Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 102. Myriad Genetics, Inc. Recent Development
Table 103. QIAGEN N.V. Company Detail
Table 104. QIAGEN N.V. Business Overview
Table 105. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product
Table 106. QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 107. QIAGEN N.V. Recent Development
Table 108. Quest Diagnostics Incorporated Company Detail
Table 109. Quest Diagnostics Incorporated Business Overview
Table 110. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product
Table 111. Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 112. Quest Diagnostics Incorporated Recent Development
Table 113. Siemens Healthineers, Inc. Company Detail
Table 114. Siemens Healthineers, Inc. Business Overview
Table 115. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 116. Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 117. Siemens Healthineers, Inc. Recent Development
Table 118. Thermo Fisher Scientific Inc. Company Detail
Table 119. Thermo Fisher Scientific Inc. Business Overview
Table 120. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 121. Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 122. Thermo Fisher Scientific Inc. Recent Development
Table 123. HTG Molecular Diagnostics, Inc. Company Detail
Table 124. HTG Molecular Diagnostics, Inc. Business Overview
Table 125. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 126. HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 127. HTG Molecular Diagnostics, Inc. Recent Development
Table 128. Vela Diagnostics Pte. Ltd. Company Detail
Table 129. Vela Diagnostics Pte. Ltd. Business Overview
Table 130. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product
Table 131. Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 132. Vela Diagnostics Pte. Ltd. Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type: 2023 VS 2033
Figure 3. Commercial Assays/Tests Features
Figure 4. Laboratory Developed Tests Features
Figure 5. Direct to Consumer Test Features
Figure 6. Pre-Commercial Tests Features
Figure 7. Global NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application: 2023 VS 2033
Figure 9. Out-Patient Clinics/General Practitioners Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. NGS-Based Monitoring and Diagnostic Test Report Years Considered
Figure 14. Global NGS-Based Monitoring and Diagnostic Test Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global NGS-Based Monitoring and Diagnostic Test Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region: 2023 VS 2033
Figure 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players in 2023
Figure 18. Global Top NGS-Based Monitoring and Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
Figure 20. North America NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 22. United States NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 26. Germany NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific NGS-Based Monitoring and Diagnostic Test Market Share by Region (2018-2033)
Figure 34. China NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 42. Mexico NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 46. Turkey NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Agilent Technologies, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 49. Ancestry.com LLC Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 50. ArcherDX, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 51. Beijing Genomics Institute (BGI) Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 52. Cancer Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 53. CENTOGENE AG Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 54. F. Hoffmann-La Roche Ltd Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 55. GenePath Dx Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 56. Illumina, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 57. Laboratory Corporation of America Holdings Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 58. Myriad Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 59. QIAGEN N.V. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 61. Siemens Healthineers, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 62. Thermo Fisher Scientific Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 63. HTG Molecular Diagnostics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 64. Vela Diagnostics Pte. Ltd. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed